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ABSTRACT
Bacterial pneumonia is the leading cause of death in children under the age of five, claiming
the lives of two million children each year. Staphylococcus aureus is the extracellular Grampositive bacteria that causes necrotizing pneumonia. Moreover, the spread of antibiotic-resistant
and hypervirulent strains has made treatment more challenging. Absent in melanoma 2 (AIM2) is
a dsDNA-sensing cytosolic innate immune receptor that activates inflammasomes and is crucial
for host defense against intracellular bacteria and DNA viruses. However, its role in extracellular
bacterial pathogen-induced pneumonia is unclear. Therefore, understanding how AIM2 initiates
host responses during Staphylococcus aureus is crucial for the development of novel therapeutics
as well as prevention strategies.
To investigate more about how the AIM2 inflammasomes regulate host defense against S.
aureus infection, we used C57BL6 (wild-type) and AIM2 gene-deficient (AIM2-/-) mice in an S.
aureus-induced pneumonia model. In this model, AIM2-/- mice exhibit lower bacterial counts in
lungs, BALF, and extrapulmonary organs (liver and spleen) compared to wild-type (WT) mice. In
addition, there was an increase in immune cells (neutrophils and macrophages) in BALF of AIM2/-

mice compared to WT. Pro-inflammatory cytokines, including IFN-γ and TNF-α, were also

found to be increased in AIM2-/- mice; however, interestingly, IL-6 was found to be lower in AIM2/-

mice than in WT. Further, an intracellular killing experiment revealed that AIM2-/- bone marrow

macrophages and neutrophils have an increased ability to clear bacteria compared to their WT
counterparts. These findings suggest that the AIM2 inflammasome has a negative regulatory role
in S. aureus-induced pneumonia.
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CHAPTER 1. INTRODUCTION
Staphylococcus aureus-induced pneumonia is a primary cause of morbidity and mortality,
and is a global healthcare problem. In fact, treatment of this infection is the principal healthcareassociated expenditure in the US. While skin and soft tissue are primary targets of S. aureus,
infections of the pulmonary system and bloodstream are well documented1,2. Second to soft tissue
infection, pneumonia is a primary cause of death associated with methicillin-resistant S. aureus
(MRSA) infection. According to the CDC, in every 100,000 people living in the United States,
there were 32 cases of invasive MRSA in 2005, out of which three quarters were pneumonia3.
The CDC categorizes different strains of S. aureus based on pulsed-field gel
electrophoresis (PFGE), such as USA 100 - USA 1200. Most strains are resistant to methicillin
with the exception of USA 900 and USA 12004. Further, the majority of community-associated
MRSA infections are caused by the USA 300 strain5, which likely emerged during the early 1990s.
While S. aureus is well known for its ability to become antibiotic resistance, this is not the only
defense mechanism possessed by this bacteria. These also encode several cytolytic toxins, which
are restricted for pathogenicity and endow this pathogen with tremendous potential for immune
evasion6-8. Among these virulence factors, Panton-Valentine leucocidin (PVL) is a virulence factor
highly expressed in the USA 300 isolates that has been heavily investigated9,10. PVL is a poreforming toxin that at low doses causes apoptosis of neutrophils, while at higher doses it causes
necrosis, which is illustrated by the increased presence of neutrophils in MRSA-infected lungs10,11.
Both innate and adaptive immunity contribute to the host response in the pulmonary
system. While the innate immune response is pathogen non-specific and occurs immediately upon
infection, the adaptive immune response is pathogen-specific, occurs later, and includes memory
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responses12. Innate immune cells, including dendritic cells, macrophages, fibroblasts and
circulating leukocytes, such as neutrophils and monocytes, are located in tissues. These cells
recognize invasive pathogens through specialized pattern recognition receptors (PRRs) that
recognize damage associated molecular patterns (DAMPs) and pathogen associated molecular
patterns (PAMPs)13. Based on their cellular localization, Pattern Recognition Receptors are
allocated as cytoplasmic or membrane-bound. C-type lectin receptors (CLRs) and Toll-like
Receptors (TLRs) are membrane-bound PRRs, whereas cytoplasmic PRRs include absent in
melanoma 2-like receptors (AIM-2 like receptors or ALRs), the retinoic acid-inducible gene-I–
like receptors (RLRs), and NOD-like receptor (NLRs)14. The ligand specificities and downstream
signaling cascades of these receptors are well recognized. Moreover, intracellular double stranded
DNA (dsDNA) can trigger the immune responses and enable the discovery of new ALRs in the
future.
AIM2 is a dsDNA-sensing cytosolic innate immune receptor that activates inflammasomes
and is crucial for host defense responses to multiple pathogens, including DNA from intracellular
bacteria and viruses15. While AIM2 is composed of

pyrin domain at its N-terminus and

hematopoietic interferon-inducible nuclear proteins with a 200 amino acid (HIN-200) domain in
the C-terminus, the downstream molecule apoptosis-associated speck-like protein containing a
CARD (ASC) has a caspase recruitment domain ( CARD) domain that interacts with the CARD
of procaspase 1, leading to an oligomeric structure known as the AIM2 inflammasome and
subsequent cleavage of pro-interleukin18 and pro interlukin-1β into mature forms. Furthermore,
caspase 1 also cleaves the substrate gasdermin-D to induce downstream signaling events16.
Neutrophil influx at the site of infection is the first line of defense against bacterial
infection17. Reading the role of inflammasomes in bacteria-induced lung infection, a previous
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study from our laboratory indicates involvement of the inflammasome in neutrophil-mediated host
defense against S. aureus infection. This study showed that NLRC4 negatively regulates the
Interleukin-17 mediated neutrophil-dependent immune response through upregulation of
Interleukin-1818. In addition, mice deficient in NLRP6 demonstrate decreased neutrophil
accumulation in the lungs, and thus this positively controls host defense in the lungs by modulating
neutrophil recruitment and function19. However, the role of AIM2 inflammasome in neutrophil
recruitment upon pulmonary bacterial infection remains elusive.
Neutrophil recruitment to the lungs occurs through a series of processes involving
granulopoiesis, neutrophil release, cellular adhesion molecules, and eventual transmigration into
the alveolar space20,21. Upon severe bacterial infection, the hematopoietic system can supply
urgently needed neutrophils to counterbalance neutrophil depletion though what is known as
'emergency granulopoiesis'22. A recent paper from our laboratory illustrated that CXCL1 and
NLRP6 mediate emergency granulopoiesis in S. aureus and Klebsiella pneumoniae infections,
respectively23,24. However, there is a lack of knowledge regarding the regulation of host defense
by the AIM2 inflammasome in S. aureus-induced pneumonia. Therefore, we used AIM2-deficient
(AIM2-/-) mice to study the role of this inflammasome in the host immune response against S.
aureus-induced pneumonia. Our results show that AIM2 negatively regulates host immune
responses against S. aureus-induced pneumonia.
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CHAPTER 2. LITERATURE REVIEW
2.1. Abstract
The innate immune system is an important weapon in host defense against pathogens
possessing both intracellular and extracellular receptors to recognize potential damage signals.
Activation of a multimeric protein complex known as the inflammasome occurs upon sensing of
stimuli by intracellular immune receptors. The activated inflammasome then induces production
of mature Interleukin -18 (IL-18) and Interleukin-1β (IL1β) through the activation of procaspase1 to caspase-1, which cleaves pro IL-18 and IL-1β. Various resident cells, including epithelial
cells, in the lungs are continuously exposed to engulfed irritants and infesting pathogens. The
innate immune response is crucial in combating lung infections, and bacterial lung infection is a
significant cause of mortality, morbidity, and health care costs. Therefore, there is intense interest
in discerning the importance of the inflammasome in the pulmonary system due to the potential
for identification of novel therapeutic approaches. Here we review the interconnection between
inflammasome-mediated responses and the development of infection in the lower respiratory tract.
2.2. Introduction
Due to the continuous exposure of the respiratory tract to various environmental pathogenic
and commensal microbes a rapid, sensitive, and diverse immune response is required. Bacterial
pneumonia is a tremendous human disease burden responsible for significant morbidity, death,
and healthcare expenditures25. Thus, much focus has been directed toward identification of
immune mediators with the potential to mitigate bacterial infection. These studies rely heavily on
murine models of infection. Nevertheless, few attempts to modulate host defense mechanisms
during bacterial infections have been successful. This review highlights recent advances in
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knowledge of inflammasomes, focusing on how these molecules sense and respond to respiratory
bacterial infections.
2.3. Role of Inflammasomes in Bacterial Pneumonia
2.3.1. Bacterial Pneumonia
Pneumonia, an umbrella term for disease caused by various agents, including viruses, fungi
and bacteria, results in infection of the pulmonary parenchyma26. Despite the development of
multiple antibiotics and prevention strategies, bacterial pneumonia is the most common pneumonia
in the United States, accounting for more than 50,000 deaths per year and 1.1 million
hospitalizations26. Typical symptoms of bacterial pneumonia are high fever, chest pain, continuous
cough and shortness of breath, with severity ranging from mild to life-threatening. Complicated
cases may progress to systemic sepsis, and mechanical ventilation may be required due to
respiratory failure27. The primary method for diagnosis of bacterial pneumonia is radiographic
imaging28.
Given the constant exposure of the pulmonary system to inhaled pathogens, and the
intricate host protection mechanism coordinates the killing and clearance of micro-organisms.
Nonetheless, clinical pneumonia can develop following exposure to highly virulent pathogens or
if the pathogen burden is high. Moreover, complex virulence factors in some bacteria subvert the
host defense system and immunocompromised people are also at increased susceptibility.
Activation of sentinel cells such as macrophages results in chemokine secretion and
migration of neutrophils into pulmonary organs29. Clearance of bacteria by neutrophils occurs via
phagocytosis followed by killing through reactive oxygen species (ROS) production and
proteases30.
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2.3.2. Recognition of Microbes
The innate immune system recognizes invading pathogens and subsequently initiates
inflammatory responses. Successful recognition of microbes involves the specific ability of the
immune system to discern self from non-self, a process which is initiated when pathogen
associated molecular patterns (PAMPs) are sensed by pattern recognition receptors (PRRs) present
in immune cells31. The interaction of PAMPs with PRRs leads to an increased in cytokines and
chemokines through the activation of downstream signaling cascades, which promotes recruitment
of antigen-presenting cells and professional phagocytes to sites of infection32. Investigation of the
innate immune system lead to the discovery of four major groups of PRRs: nucleotide recognition
domain (NOD)- like receptors (NLRs), retinoic acid-inducible gene (RIG)-1-like receptors, tolllike receptors (TLRs), and absent in melanoma 2(AIM2)-like receptors33. Each PRR exhibits a
high degree of specificity for specific PAMP ligands.
2.3.3. Neutrophil Recruitment
Neutrophils, the most abundant type of granulocytes, are short-lived bone marrow-derived
cells34. Upon recruitment from the circulation to the lung during bacterial pneumonia, neutrophils
release antimicrobial products or perform phagocytosis to kill bacteria. Granules contained in
neutrophils contain defensins, myeloperoxidase (MPO), elastase, and cathepsins35. Patients with
neutrophil defects are prone to bacterial infections, thus underscoring the crucial role of
neutrophils in combating these infections. Nevertheless, neutrophils can also cause injury to host
tissues and their activation must be tightly regulated.
Priming of neutrophils via an inflammatory response enhances their oxidant production
and other effector functions36. Cell-associated PRRs in neutrophils, including AIM2-like
receptors, NLRs, C-type lectin receptors, and RIG-I helicase receptors, recognize microbes or
6

microbial products through pathogen-associated molecular patterns (PAMPs) or danger associated
molecular patterns (DAMPs). The activated PRRs then trigger intracellular signaling cascades,
which result in production of ROS, degranulation, phagocytosis, and cytokine/chemokine
production35.
Inflammatory stimuli initiate the migration of neutrophils to infected tissues, where the
attachment, engulfment, and inactivation of bacteria by neutrophils takes place37. Bacterial
clearance by neutrophils depends on the production of ROS, which is catalyzed by
myeloperoxidase (MPO) and NADPH oxidase. The formation of neutrophil extracellular traps
(NETs) has been recently reported as a unique mechanism of neutrophil-mediated microbe
killing38. NETs are extracellular chromatin decorated with histones and numerous granular
proteins37. The formation of NETs starts with cellular activation through numerous stimuli and
activation of NADPH complex, which in turn activates protein-arginine deiminase type 4 (PAD4),
neutrophil elastase, and MPO. In addition, production of ROS is essential to initiate NETosis39,40.
Recruitment of neutrophils to the lungs involves granulopoiesis, neutrophil release, cellular
adhesion molecules, and eventual transmigration into the alveolar space20. During bacterial
infections, the hematopoietic system can supply urgently needed neutrophils to counterbalance
neutrophil depletion through a mechanism known as emergency granulopoiesis. A recent paper
from our laboratory illustrates that CXCL1 and NLRP6 mediate emergency granulopoiesis during
S. aureus and K. pneumoniae infections, respectively23,24.

2.3.4. Alveolar Macrophages

Alveolar macrophages (AMs) are specialized tissue macrophages that reside in the alveolar
space 41. Further, AMs constitute 93% of lung macrophages with the remainder being interstitial
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macrophages42, and both play an essential role in host defense. AMs eliminate microbes through
secretion of lysozyme, proteases, oxygen metabolites, and through immune signaling via PRRs
and phagocytosis43. The binding of both opsonized or non-opsonized microbes to several receptors
on macrophages initiate phagocytosis.

Moreover, in addition to being central players in the recruitment of activated neutrophils
into alveolar spaces via cell-to-cell signaling, AMs sense microbial PAMPs through PRRs
resulting in microbe phagocytosis and killing. Furthermore, upon encountering pathogens, AMs
can produce vast arrays of cytokines, including IL-6, tumor necrosis factor (TNF-α) and IL-8, and
may trigger lung injury44.

2.3.5. Epithelium

The lung epithelium is a major battleground in combat against microbial infections. The
lower respiratory tract is lined by the ciliated epithelial cells, which become non-ciliated in the
respiratory bronchioles, while flattened type I epithelial cells are the predominant cell type in the
alveolar surface45. Type II cuboidal epithelial cells are also found in the alveolar surface and
secrete surfactants and surfactant proteins A and D, which are antibacterial collectins that project
into the subepithelial structures of the lungs46. The mucus layer and the beating movement of the
cilia trap pathogens (potentially infectious microorganisms) and other particles and propel them
back towards the oropharynx. The function of epithelial cells is not restricted to their antibacterial
functions as they also participate in innate immune responses via expression of bacterial
recognition molecules (PRRs) and subsequent proinflammatory signaling cascades. This network
of proinflammatory mediators recruit leukocytes directly into air passages. Furthermore, the
airway epithelium is stimulated by the bacterial products to produce chemotactic signals resulting
8

in the recruitment of inflammatory cells into airways. Lung epithelial cells also produce
Interoleukin-8, Interoleukin-1b, Interoleukin-6, granulocyte-macrophage colony-stimulating
factor (GM-CSF), and TGF-B (transforming growth factor-b)47.

Understanding of the crucial role of lung epithelial cells in innate immune responses and
microbial defense has been bolstered by transgenic mouse studies48. Similar to immune cells,
airway epithelial cells generate chemokines and cytokines through activation of transcription
factors, including nuclear factor-κB (NFκΒ), nuclear factor interleukin 6, and activator protein-1.
Selective blockade of NFκ-B in alveolar epithelial cells was found to significantly attenuate the
production of chemokines and cytokines and the degree of inflammatory cell infiltrates after
bacterial challenge48.

2.3.6. Pathogen Recognition Receptors (PRRs)

Upon microbial infection the body must mount a response to the potentially harmful
pathogens. This is accomplished through specialized receptors known PPRs, which are expressed
by innate immune cells. and recognize the endogenous DAMPs as well as PAMPs49. PRRs play a
pivotal role in homeostasis and host defense mechanisms, as they possess the ability to synergize
and converge their signaling pathways, resulting in the orchestration of a complex interplay of
transcription factors and cellular mediators. Currently, PRR families are divided into intracellular
PRRs and transmembrane receptors. The transmembrane receptors include CLRs and TLRs on the
cell surface, as well as those that reside in intracellular compartments such as NLRs, ALRs, and
RLRs14,49. Although these receptor families differ structurally, their signal transduction cascades
converge leading to production of proinflammatory transcription factors such as NF-κB and
subsequent production of type I interferon

50

. Moreover, inflammasome-activating ALRs and
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NLRs induce the release of active IL-18 and IL-1β and pyroptosis-mediated cell death. These two
cytokines bind the transmembrane receptors IL-1R and IL18R, respectively, and promote
inflammation through the NF-κB pathway, which subsequently activates MyD88, a central adaptor
molecules associated with downstream signaling in order to induce innate immunity51.

2.3.7. Cytokines/Chemokines

Small intercellular signaling proteins known as cytokines are secreted by various cells and
are usually less than 80 kDa in size52. They possess a wide range of biological functions, including
regulating both innate and adaptive immune systems, inflammation and repair, hematopoiesis, and
proliferation through extracellular signaling53. Functionally, cytokines are classified into five
families: chemokines, interleukins, growth factors, interferons, and TNF ligands54. The role of
cytokines and chemokines in the pulmonary immune response to several pathogens, with focus on
bacterial infections, are highlighted below.

2.3.7.1. TNF-α

The production of the tissue necrosis factor- alpha (

TNF-α) is not restricted to

macrophages as a wide assortment of other cell types, including lymphoid cells, mast cells,
neutrophils, CD4+ T, NK cells adipose tissue and fibroblasts, also produce this cytokine. Produced
in response to microbial pathogens and other cytokines, like IL-155,56, TNF can bind TNF type 1
(TNFR1) and TNF type 2 receptors (TNFR2)57. TNF-α stimulates the expression of neutrophil
adhesion molecules (ICAM-1 and VCAM-1), cytokine release, as well as enhances functions of
the immune system such as the phagocytic function of macrophages, production of ROS, and
promotion of NFκ-B activation to release proinflammatory cytokines58. Furthermore, this cytokine
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activates the MAP kinase pathway and can also induce death signaling59,60. Under
pathophysiological conditions, including the inflammatory disease state, the level of TNFα
increases and is associated with the development of inflammatory responses. Moreover, the
pathological function of TNFα is implicated in various pulmonary diseases, including pneumonia,
acute lung injury (ALI), asthma, chronic bronchitis (CB), acute respiratory distress syndrome
(ARDS), and chronic obstructive pulmonary disease (COPD)61. In addition to its role in
inflammatory events, it is also reportedly involved in cytotoxicity61. Furthermore, one study
indicated that endogenous TNF plays a critical role in host defense in murine Klebsiella
pneumonia62.

2.3.7.2. IL-6
Interleukin (IL)-6 is produced primarily by macrophages and monocytes in response to
PAMPS (LPS, microbial nucleotides), and exerts either pro- or anti-inflammatory functions63
depending on the setting. IL-6 binds the IL-6 receptor leading to activation of the associated gp130
signal-transduction component resulting in regulation of cell growth and proliferation, immune
responses, and cellular apoptosis. IL-6 interacts with the IL-6Rα chain64. Of three important
proinflammatory monokines, (IL-1, TNF-, and IL-6) IL-6 induces acute phase serum protein
synthesis in adult human hepatocytes65. Compared with WT mice, IL-6 -/- mice showed increased
mortality and bacterial burdens with pulmonary lesions associated with early bacterial
dissemination to extrapulmonary organs during pneumonia following co-infection with influenza
and Streptococcus. This protective immune function of IL-6 is accompanied by increased
apoptosis and macrophage function66. Furthermore, in Escherichia coli infection, IL-6-/- mice
demonstrate decreased neutrophil numbers in airways, suggesting that IL-6 augments neutrophil
recruitment and decreases bacterial burdens through activation of STAT transcription factors67.
11

2.3.7.3. IFN-γ
Interferon-gamma (IFN-γ), a type II interferon that possess anti-tumor, antiviral, and
immunoregulatory properties, is a dimerized soluble cytokine68 secreted by cytotoxic T cells, T
helper cells (specifically, Th1 cells), NK cells, mucosal epithelial cells, and macrophages. Binding
of the IFN-γ receptor 1 (IFNGR1) and 2 (IFNGR2) by IFN-γ induces activation of the JAK-STAT
signaling pathway resulting in downstream cellular responses69. IFN-γ plays a crucial role
in innate and acquired immunity against viral, bacterial, and protozoan infections. Furthermore,
IFN-γ activates macrophages resulting in augmenting killing of intracellular organisms70. One
study illustrated that in comparison with immunocompetent mice, IFN-γ gene KO mice have a
higher mortality rate suggesting a protective role for this cytokine in the host response to
pneumococcal disease71. In contrast, another article suggested that endogenous IFN-γ is not
protective against pneumococcal pneumonia72. The reasons for the discrepancy between these
studies need to be explored by additional studies.

2.3.7.4. IL-18

Interleukin-18, from activated macrophages and dendritic cells, exerts several
proinflammatory effects that drive the development of T helper 1(TH1) cells. In addition,
numerous non-hematopoietic cells, including

keratinocytes, intestinal epithelial cells

and endothelial cells72, also express IL-18. Caspase-1 cleaves pro-IL-18 into its mature form which
binds IL-18Rα, resulting in recruitment of IL-18Rβ through the toll/interleukin-1 receptor (TIR)
domain on IL-18Rα. Furthermore, this downstream signal results in activation of MyD88 followed
by the NF-κB pathway and proinflammatory programs including the production of Th1cell cytokines like IFN-γ and granulocyte macrophage- colony stimulating factor (GM-CSF)73.
12

Interleukin-18 plays a role as a negative regulator in the secretion of the anti-inflammatory
cytokine Interleukin-10. Further, Interleukin-18 can control innate and adaptive immune
responses

either

negatively

or

positively

and

its

dysregulation

may

lead

to

autoimmune or inflammatory diseases74,75. Many studies suggest that IL-18 is essential in the
pathogenesis of pulmonary diseases like COPD and bronchial asthma75. In addition, during
Pseudomonas infection IL-18 deficiency is associated with a decreased bacterial burden in the
lungs and reduction in the spread of infection76

2.3.7.5. IL-1β
Interleukin 1 beta (IL-1β), an immunoregulatory and proinflammatory cytokine, is a
member of an interleukin 1 family of cytokines. Induction of IL-1 occurs in response to select
PAMPs or DAMPs and subsequent inflammasome and caspase-1 activation molecule77. Moreover,
activated macrophages also produce IL-1β, which can have several cellular activities, including
the induction of cell proliferation and apoptosis.

2.3.7.6. IL-17
The IL-17 cytokine belongs to a family of proinflammatory cytokines secreted by a group
of CD4+ T helper cells (Th17) in response to stimulation with IL-23. The six members (IL-17A
through IL17F) of this family are not homologous to other cytokines. IL-17R, IL-17RH1, IL17RL, IL-17RD, and IL-17RE are all well-known receptors for the IL-17 family. IL-17A, also
known as IL-17, is produced mainly by Th17 cells, but also by other cell types, such as CD8+ T
cells, neutrophils, and eosinophils. IL-17A induces IL-8, IL-6, and granulocyte colony-stimulating
factor (GM-CSF) in cells that express the IL-17 receptor. Furthermore, IL-17 plays a key role in
the recruitment of neutrophils, although its effects on pulmonary immunity lie beyond neutrophil
13

recruitment, as it can increase mucus production and induce goblet cell hyperplasia in the bronchial
epithelium. According to one study, IL-17A and IL-17F are upregulated in chronic obstructive
pulmonary disease indicating the central role of this cytokine in this disease pathophysiology78. In
pneumonia-induced sepsis, IL-17 signaling leads to inflammatory cell death, known as
pyroptosis79. Moreover IL-17 bridges the innate and adaptive immune responses and exerts both
pathological and beneficial effects on the host immune system80.

2.4. Inflammasomes
Inflammasomes are distinct oligomeric cytosolic structures of the innate immune system
that activate inflammatory responses. Major components of the inflammasome include various
PRRs, such as AIM2 and nucleotide-binding NLRs49, which are responsible for the processing of
caspase-1 leading to the proteolytic cleavage, maturation, and generation of inflammatory
cytokines IL-18 and IL-1. DAMPs and PAMPs binds with the pro-caspase-1 protein complex
formed by AIM2 or NLR in association with adapter molecule like apoptosis-associated speckcaspase recruit domain (ASC) to form an inflammasome49. Inflammasomes play a central role in
the coordination of host defenses and induction of inflammatory cascades through the maturation
and production of proinflammatory cytokines and the initiation of immune-stimulatory
programmed cell death termed pyroptosis81. Some studies have suggested that erratic activation of
inflammasomes is a razor's edge for chronic inflammatory, autoimmune, metabolic, and
autoinflammatory diseases. Therefore, harsh activation of inflammasomes needs to be restricted
in order to minimize undesirable host damage and inflammatory responses.
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2.4.1. NLR subset of inflammasomes
The NLR subset of inflammasomes includes NLRC4, NLRP3, NLRP6, and NLRP1, which
have two common features, a nucleotide-binding oligomerization domain (NOD) for selfoligomerization and a leucine-rich repeat (LRR) domain at the C-terminus that recognizes ligands
of other receptors82. Upon ligand binding, NLR proteins form inflammasomes which recruit procaspase1 via a CARD-CARD interaction. Caspase 1, in turn, promotes the activation and
maturation of pro-IL-1β and pro-IL-18 into mature IL-1β and IL-18, which may be responsible for
the induction of pyroptosis. The inflammasome adaptor protein apoptosis-associated speck-like
protein containing a CARD (ASC) consists of a caspase recruitment domain (CARD) and a pyrin
domain (PYD) and assembles into large protein complexes known as ASC specks, a hallmark of
inflammasome activation83. Here, we discuss various inflammasome structural and molecular
patterns, their signaling cascades, and their role in bacterial pneumonia.

Figure 1. Mechanism of Inflammasome Activation
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2.4.1.1. NLRP1

The NLRs are structurally different molecules. NLRP1 contains an N- terminal pyrin
domain (PYD) and C- terminus FIIND motif and a CARD in addition to an NOD and LRR81. The
LRR domain is sandwiched between PYD and the central NOD. Once activated, the C-terminal
CARD interacts with the CARD of caspase 5 thorough a homotypic reaction while the N-terminus
binds the PYD of the bipartite adaptor protein ASC, which recruits and induces pro-caspase-1
through its CARD domain84,85. Constituents of the NLRP1 inflammasome system are believed to
be CARD8, ASC, caspase-1, and caspase-585,86. The cleavage of procaspase-1 induces the
downstream caspase-1 signaling pathway, and caspases 1 and 5 are necessary for activation of the
NLRP1 inflammasome, which induces maturation and production of IL-1β. Activation of the
NLRP1 inflammasome involves a two-step process with the first step being priming of the central
NACHT domain for NTP through binding of NLRP1 LRR to bacterial MDP PAMP, which leads
to NLRP1 oligomerization and recruitment of procaspase 1. Although ASC increases the activity
of NLRP1, NLRP1 can interact with procaspase-1 bypassing the ASC molecule as it is equipped
with a C-terminal CARD domain85,87. One study showed that Bacillus anthracis induces NLRP1
assembly and initiation of pyroptosis, which leads to acute lung injury eventually resulting in host
mortality88. However, significantly detailed studies regarding the role of the NLRP1
inflammasome in human health are lacking.
2.4.1.2. NLRP3
The NLRP3 inflammasome is a tripartite protein which contains: 1) a C-terminal LRR
domain 2) a central nucleotide-binding and oligomerization domain (NACHT domain), 3) an
amino-terminal pyrin domain (PYD)89. The NLRP3 inflammasome is activated through binding
of the NLRP3 pyrin domain with the pyrin domain of ASC90. Inflammasome activation involves
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a two-step mechanism. First is a priming step downstream of TLR activation that results in
upregulation of pro-IL-18, pro-IL-1β, and the components of inflammasomes, initiated by various
PAMPs and DAMPs. The second step is the activation and maturation step which involves the
congregation of the constituents into the inflammasome structure and subsequent induction of
proinflammatory interleukins91,92. Heterogeneous compounds including bacterial PAMPs, silicon,
ozone, asbestos are all NLRP3 ligands. The NLRP3 stimuli can induce various molecular and
cellular signaling events. Currently, three signaling events have been identified, including the
generation of reactive oxygen species (ROS), ionic flux, and lysosomal disruption93-95. ROS
production is the most common upstream signal as ROS inhibitors affect NLRP3 inflammasome
assembly96,97.
Inhalation of silica crystals causes significant crystal phagocytosis resulting in NLRP3
activation and consequent lysosomal rupture93. The ion channel function of the purinergic receptor
P2X7 activates ATP-dependent potassium efflux and calcium influx, resulting in NLRP3
inflammasome activation. In addition, the NLRP3 inflammasome plays a key role in host defense
against bacterial, viral, and fungal infections98-101; however, its dysregulation is related to the
pathogenesis of several inflammatory disorders, including Alzheimer's disease, pulmonary
fibrosis, autoinflammatory disease, diabetes, atherosclerosis, and gout102,103.
2.4.1.3. NLRC4
NLRC4 contains a C-terminal LRR, a central nucleotide-binding/ NACHT domain, and an
N-terminal CARD domain. It includes the canonical inflammasome protein NLRP3 as well as
transcriptional co-activator CIITA. However, requirement of the ASC adaptor, like in other
inflammasomes, is not well established for NLRC4, since it is equipped with its own CARD
domain104. Legionella activates two independent pathways, the ASC pathway and NLRC4-NAIP
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inflammasome, to activate caspase-1105. Upon activation both pathways induce production of IL18 and IL-1B, but ASC activity doesn't induce NLRC4/NAIP-mediated pyroptosis105. One study
suggested that both pathways are centralized at the ASC molecule, which functions in both
pyroptosis and proinflammatory cytokine release106. A recent study illustrated that both human
and murine macrophages activate NLRC4 in response to K. pneumoniae infection. Thus, the
NLRC4 inflammasome is a critical player in host immune defense in in vivo models107. However,
detailed study of the role of NLRC4 in immune protection against additional bacterial pulmonary
diseases is needed.

2.4.1.4. NLRP6 and NLRP12

Two recently recognized members of the NLR family, NLRP6 and NLRP12, form an
inflammasome that oligomerizes with ASC. However, there is a lack of knowledge regarding the
detailed downstream signaling mechanisms, structural assembly, and role of this inflammasome
in host defense108-111. In contrast to other inflammasomes, NLRP6 and NLRP12 appear to be
involved in anti-inflammatory responses. The presence of the NLRP6 in various cells, such as
epithelial cells, macrophages, T cells and neutrophils112, makes NLRP6 a strong candidate for host
defense of the pulmonary system. Further, NLRP6 is highly expressed in the intestine and liver
where it regulates inflammation and host defense mechanism against microbes112. Nonetheless,
the role of NLRP6 is not restricted to inflammasome activation, as it also regulates nuclear factorkB (NF-kB) signaling, antiviral interferon signaling, mitogen-activated protein kinase (MAPK),
antimicrobial peptide (AMP) production, and mucus secretion113,114. A study conducted in our
laboratory using the S, aureus model revealed that Nlrp6 KO bone marrow-derived macrophages
(BMDMs) exhibit decreased caspase-1 dependent IL-β secretion in comparison to WT BMDMs114.
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In association with these results, reduced IL-1β was found in bronchoalveolar lavage fluid of
MRSA-infected Nlrp6−/− mice compared to that of WT mice113. Thus, together these reports
suggest that Nlrp6 assembles an inflammasome during microbial infections.
The NLRP12 was the first NLR found to be solely produced by monocytes, eosinophils,
and granulocytes115. While NPRP12 is believed to function as negative regulator in both canonical
and noncanonical NFκB signaling pathways111, there is a lack of knowledge regarding its role in
the innate immune response. In Yersinia pestis infection, NLRP12 is responsible for the
suppression of IL-1β and IL-18 production, and IL-18 mediated IFN-γ110.
2.4.2. AIM2 Inflammasome
AIM2 was the first member of the ALRs family identified and consists of (1) a C-terminal
HIN domain, which interacts with double-stranded DNA (dsDNA) and (2) an N-terminal PYD
domain, which binds to ASC via a PYD-PYD homotypic interaction. Situated in the cytosol, AIM2
is activated in response to dsDNA of bacterial or viral origin116-118
In addition, the binding of AIM2 with ASC results in the activation of procaspase-1 and
subsequently, the maturation and production of IL-18 and IL-1β cytokines. In contrast, AIM2mediated inflammatory responses are inhibited by interaction with the p202 molecule15.
The role of AIM2 in many bacterial infections, including cytosolic bacterium Fransicella,
Listeria monocytogens, and Mycobacterium tuberculosis119,120 has been established. Furthermore,
AIM2 is also known to be important for host defense against various viral infections, including
vaccinia, murine CMV, and HSV121,122. A recent study revealed that the AIM2 inflammasome
regulates IL-1β release and has survival benefits in acute S. aureus infection of the CNS123.
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Moreover, in Plasmodium burghei infection, Aim2–/– mice show impaired neutrophil recruitment
in the peritoneal cavity124.
Several studies in mice have suggested a detrimental role of AIM2. For example, studies
of the AIM2-/- mouse revealed suppression of tumor cell growth, reduction of cancer cell viability,
and onset of apoptosis in tumor cells as compared to WT mice124,125. In addition, RNA virus
influenza A virus (IAV) infected AIM2- deficient mice displayed reduced lung injury and had
increased survival as compared to their WT counterparts125. Collectively these findings
demonstrate that activation of AIM2 is a double-edged sword. While this molecule can serve as a
DAMP sensor triggering the inflammasome in response to self-DNA, activation of AIM2 can also
cause excess cell death and tissue injury.

2.5 Perspective
In general, there is a link between the parallel signaling pathways and unrelated molecules
between the innate immune system components. Despite vast knowledge of innate immune
responses, more exploration of the link between immune system pathways is essential to further
understanding of the comprehensive molecular mechanisms underlying host defense against
invading pathogens. This knowledge will help to identify novel therapeutics interventions
including manipulation of host defense mechanisms. Identification of TLRs, NLRs, and
inflammasomes and their ability to trigger proinflammatory cytokine responses is the primary and
foremost step needed for thorough understanding of the immune system. Moreover, it is apparent
that the specificity of PRR and PAMP interactions is not complete, as activation of a specific PRR
could result in the simulation of various signaling pathways. Thus, although there have been
considerable discoveries, many unanswered questions remain including those regarding the
detailed understanding of the interaction between various PRRs in response to pathologic triggers.
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This knowledge is necessary for development of more enhanced and sophisticated therapeutic
interventions for several infectious, neoplastic, and autoimmune diseases of pulmonary and
extrapulmonary organs.

Figure 2. Mechanism of AIM2 Inflammasome Activation
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CHAPTER 3. MATERIALS AND METHODS
3.1. Mice
Specific Pathogen-free (SPF) WT (C57BL/6) and AIM2-/- male and female mice from
Jackson Laboratory of 8 to 10-weeks of age and weight of 22-25 g were used in all experiments.
The mice were kept in a bacteria-free environment and were fed mouse chow and water ad libitum
with a 12 hour dark and 12 hour light cycle. All animal experiments were done with approval from
the Louisiana State University (LSU) Animal Care and Use Committee.
3.2. Bacterial Preparation
In brief, S. aureus (USA300) was grown as described previously19. The bacterial
suspension was then diluted to the required concentration of 5*10^7 CFU/50 µl in PBS for acute
pneumonia studies.
3.3. Pneumonia model
S. aureus (USA 300) strains were used to induce pneumonia as described126. In brief, to
induce pneumonia ketamine (100 mg/kg) and xylazine (5 mg/kg) were used to anesthetize the mice
before intratracheal inoculation of S. aureus (USA 300). To expose the trachea a small mid-ventral
incision was made on the ventral side of the neck. Then through the exposed trachea 50 microliter
of S. aureus suspension containing 5*107 CFU in isotonic saline was inoculated using a 28.5-gauge
needle. After euthanizing the mice, the BALF, lungs, and extrapulmonary organs (spleen and liver)
were harvested at 12 or 24 hours post-infection, respectively, for estimation of bacterial burden
and leukocyte recruitment. The BALF and homogenized organ samples were serially diluted in
isotonic saline and plated onto Tryptic soy agar (TSA) and/or McConkey plates for bacterial
quantification.
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3.4. Macrophage Isolation
For bone marrow-derived macrophages (BMDMs), after harvesting tibias and femurs,
cells were collected by repeated flushing with PBS. After RBC lysis, remaining cells were
centrifuged and washed. After washing, cells were cultured in a T75 flask with complete DMEM
(containing penicillin/streptomycin (100 U/ml) and 10% FBS). On alternate days, murine-colony
stimulating factor (mCSF) (final concentration of 50 ng/ml) was added for 7 days until they
differentiated into macrophages.
3.5. Isolation of Neutrophils
The bone marrow-derived neutrophils (BMDNs) were isolated as previously described23.
In brief, after RBC lysis bone marrow cells were passed through enriched neutrophil isolation
cocktail Easy Sep neutrophil isolation kit, which uses magnetic negative selection. (STEMCELL
Technologies)
3.6. Intracellular Neutrophil Killing Assay
The intracellular killing assay using BMDNs was conducted as described previously127.
The neutrophils of both wild-type and AIM2 knockout mice were purified from bone marrow using
EasySep™ Mouse Enrichment Kit from Stemcell™ Technologies as indicated in the
manufacturer’s protocol. Then 0.25×106 isolated neutrophils were allocated in 96 well plates and
infected with S. aureus (MOI: 10). After 1 hour long of infection, cells were treated with
gentamycin (250 ug/ml) to kill extracellular bacteria. To remove excess gentamicin, cells were
washed several times with sterile PBS and 120 μL 0.1% Triton-X was used to release intracellular
bacteria at the designated time points of 30 min, 60 min, 90 min, and 120 min. The lysate was

23

serially diluted with PBS and 20 µl of the sample was plated in tryptic soy agar and incubated at
370C overnight to estimate the bacterial burden.
3.7. Macrophage Killing Assay
Macrophages of both WT and AIM2 knockout mice were isolated from bone marrow.
Then 0.25x106 isolated macrophages were allocated into 96 well plates and incubated overnight.
After incubation, the media was changed with DMEM containing 10% FBS and plates were then
incubated again at 370C with 5% CO2 for 3 hours. Macrophages were infected with S. aureus
(MOI 10) and then at designated time points (1 h, 2 h, 4 h, 8 h, and 12 h) cells were washed several
times with sterile PBS, and 120 μL 0.1% Triton-X was used to release intracellular bacteria. For
4-, 8-, and 12-hour time points, the cells were treated with gentamycin (250 μg/ml) for 1 h postinfection followed by 25 μg/ml gentamycin for the next 3 h post-infection. To remove excess
gentamicin, cells were washed thrice with sterile PBS and then the cell lysate was serially diluted
in PBS, and 20 μl of the aliquot was plated on tryptic soy agar plates and incubated at 370C
overnight to estimate the bacterial burden.
3.8. Cytokine Measurement
As described in an earlier publication, cytokines/chemokines were evaluated by sandwich
enzyme-linked immunosorbent assay (ELISA)126,128,129. Cytokine levels in BALF samples, lung
homogenates, and BMDM supernatants were measured with mouse IL-18, TNF-α IL1β, LIX,
MIP2, IL23, IL6, and IL17A kits (e-Bioscience).

24

3.9. Statistical Analyses
All data are shown as means ± SEM. All data were analyzed by using one way ANOVA or by two
tailed t-test, as appropriate. All the statistical tests were conducted using GraphPad Prism 9
software and p<0.05 considered significant.
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CHAPTER 4. RESULTS AND DISCUSSION
4.1. Results
4.1.1. AIM2-/- mice exhibit increased immune cell recruitment in bronchoalveolar lavage fluid
(BALF) post-S. aureus challenge.
Macrophages and neutrophils are the first line of defense against bacterial infections such
as S. aureus. To assess the recruitment of immune cells in airways, we assessed total and
differential leukocyte counts in BALF at 12- and 24-hours post-S. aureus (5*107 CFU/mice)
challenge. We found an increased concentration of leukocytes in both WT and AIM2-/- mice after
12 hours of bacterial challenge, while the leukocyte count decreased at 24-hours post-infection in
both types of mice. However, the AIM2-/- mice had a higher total cell count in BALF at 24 hours
compared to the WT counterpart. Further, it should be noted that compared to WT mice,
differential cell counts in AIM2-/- mice showed higher neutrophils and macrophages at 24 hour
post infection. However ,both showed similar cellular response at 12 hour post infection.
A

B

C

Figure 3. Recruitment of (A) Total leukocytes, (B) neutrophils, and (C) macrophages in both WT (C57Bl/6) and
AIM2-/- mice at 12 and 24 hours post-infection with S. aureus (n=5-7 mice/group)
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4.1.2. AIM2-/- mice show increased bacterial clearance from BALF and lungs.
As adequate macrophage and neutrophil recruitment are necessary for the clearance of
bacteria, we estimated the bacterial burden in the lungs as well as in the BALF fluid. To measure
the local bacterial burden, we intratracheally infected mice with S. aureus and 12 or 24 hours later
mice were sacrificed, lungs were harvested, and BALF was collected. Both WT and AIM2-/- mice
had a maximum bacterial burden in the lungs and BALF at 12 hours, which decreased at 24 hours
post-infection. In addition, AIM2-/- mice demonstrated a decreased bacterial burden in lungs and
BALF as compared to WT mice at 12 and 24 hours post-bacterial challenge, which correlates with
the increased neutrophil recruitment in airways.
A

B

Figure 4. Bacterial burden in (A) Lungs and (B) BALF of WT and AIM2-/- mice 12- and 24 hours post-infection
with S. aureus. (n=5-7 mice/groups)

4.1.3. AIM2-/- mice displayed decreased bacterial dissemination to the extrapulmonary organs
(spleen and liver).
In this model, we found a lower local bacterial burden in AIM2-/- mice than in their WT
counterparts. Therefore, we next wanted to look at bacterial dissemination to the extrapulmonary
organs including liver and spleen. For this, at 12 and 24 hours post-infection, we sacrificed WT

27

and AIM2-/- mice and harvested the liver and spleen to assess bacterial loads. We found the
bacterial burden in AIM2-/- mice was significantly reduced as compared to WT mice.
B

A

Figure 5. Bacterial burden in (A) liver and (B) spleen of both wildtype and AIM2-deficient mice following S. aureus
infection. (n=5-7 mice/group)

4.1.4. AIM2 deficiency increases the production of IFN-γ.
Several cytokines and chemokines have effects on host defense and neutrophil recruitment.
Thus, in this experiment we analyzed cytokines in the BALF of both WT and AIM2-/- mice at 12and 24-hours post-infection. Our results show that AIM2-/- mice have higher levels of TNF-α and
IFN-γ in BALF. In contrast with this result, surprisingly, we found a lower level of IL-6 in BALF
of AIM2-/- mice compared to their WT counterparts.
4.1.5. AIM2-/- neutrophils clear a higher number of bacteria compared to WT neutrophils.
Neutrophils are the primary immune cells recruited after bacterial infection. As we found
an increased presence of neutrophils in the BALF fluid of AIM2-/- mice, we were interested in
whether AIM2-deficient neutrophils are responsible for increased bacterial clearance. For this
reason, we isolated neutrophils from the bone marrow of both WT and AIM2-/- mice and performed
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an intracellular killing assay. In 30 minutes, AIM2KO neutrophils showed enhanced intracellular
killing compared to WT but at 60 and 90min time points, there were no significant difference
between WTs and AIM2KO.
4.1.6. AIM2-/- macrophages have increased bacterial burdens compared to WT macrophages.
As we found a higher level of macrophages in the AIM2-/- mice compared to their WT
counterparts, we next performed bone-marrow-dependent intracellular killing assays using both
wild-type and AIM2-/- macrophages. Similar to neutrophils, BMDM killing assay revealed
enhanced MRSA killing by AIM2KOuts when compared with WTs and the significant different
was noted in 1,2 and 12-hour time points.
A

B

C

Figure 6: Concentration of (A) TNF-α, (B) IFN-γ, and (C) IL-6 in BALF of WT and AIM2-/- mice 12- and 24-hours
post-infection with S. aureus. (n=5-7 mice/group)

4.2. Discussion
Gram-positive bacteria-induced pulmonary diseases are a significant cause of mortality,
morbidity, and healthcare-associated economic loss in both immunocompromised and
immunocompetent people130,131. The increase in strains of multi-antibiotic resistant bacteria
(superbugs), the growing
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Figure 7. Bone marrow-derived neutrophil killing assay comparing neutrophils isolated from WT and AIM2-/- mice.

number of elderly, and the considerable number of immunocompromised people all limit the
efficacy of currently available antibiotics. Therefore, identification of novel therapeutic targets,
including those within the host defense system, is warranted. Because the pulmonary system is
consistently exposed to pathogens and virulence factors, the host defense system is complex in
nature. Activation of the innate immune system through germline-encoded PRRs is the first layer
of defense against pathogens85. Specific microbial components are recognized and then activate
various inflammatory pathways to impede microbial invasion85. The activation of the
inflammasome is the primary endpoint of these inflammatory pathways. Inflammasomes,
including AIM2, are cytosolic PRRs, or sensors, essential for bacterial clearance. Furthermore,
AIM2 is a quintessential gene involved in formation of the inflammasome85.
Recruitment of adequate numbers of immune cells, including neutrophils and
macrophages, to the lungs and airways is essential for host defense against pathogens like S.
aureus. Following S. aureus infection NLRP6-/- mice exhibit an increased neutrophil presence in
BALF, which is associated with improved bacterial clearance from pulmonary and extrapulmonary
organs19. In keeping with this, AIM2-/- mice display increased neutrophil and macrophage
recruitment in the BALF, with appreciably improved bacterial clearance. It should be noted,
however, that in contrast with our results, a protective role of AIM2 has been reported in
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pneumococcal pneumonia with decreased survival and higher bacterial burden in AIM2-/mice132,133.
The interaction of AIM2 with ASC results in generation of the ASC pyroptosome which
induces pyroptotic cell death in caspase-1 containing cells133. Using an in vivo superinfection
model, one study revealed that ASC–/– mice are highly resistant to influenza/S. aureus
superinfection134, while NLRP3-/- mice have slightly more susceptibility than WT mice to
pneumococcal pneumonia135. Our study also illustrates that AIM2-/- mice are highly resistant to S.
aureus infection, which might be due to the interaction of AIM2 with the ASC molecule.

Figure 8. Bone marrow derived macrophage killing assay using macrophages isolated from bone marrow cells of both
WT and AIM2-/- mice.

During S. aureus infection, the immune system responds through upregulation of cytokines
and chemokines, vascular leakage, and recruitment of neutrophils into alveolar space 136,137. In our
study, we found augmented IFN-γ levels in the BALF of AIM2-/- mice as compared to WT control
mice. In agreement with these results, another study showed that NK-cell mediated IFN-γ secretion
dampens host defense in NLRP6 KO mice by hindering ROS production and bacterial clearance
by neutrophils19. In addition, we found decreased bacterial clearance by AIM2-/- neutrophils in the
intracellular neutrophil killing experiment. Moreover, the bacterial killing ability of the AIM2 -/macrophages is greater than that of WT macrophages, which reflects the result of increased
bacterial clearance in pulmonary and extrapulmonary organs of AIM2-/- mice.
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In conclusion, our study shows that the AIM2 inflammasome is detrimental in S. aureusinduced pneumonia and negatively regulates host defense against S. aureus infection through
impairment of IFN-γ production.
4.3. Future Direction
Here we demonstrate that the AIM2 inflammasome negatively regulates host defense
against S. aureus infection. Thus, the presence of AIM2 in WT mice results in decreased IFN-γ
expression compared to that of AIM2 knockout mice. Additional studies will be necessary to
identify the cells responsible for the production of IFN-γ. NETosis is a unique feature used by
neutrophils to kill extracellular pathogens37. NETS are composed of numerous molecules,
including citrullinated histones, alpha-defensins, MPO and neutrophil proteases, which trap and
eventually kill extracellular bacterial pathogens37,138. NETosis is dependent on NADPH-dependent
ROS production and thus, AIM2-dependent NETosis may be mediated through ROS generation139.
Therefore, it will be interesting to quantitate the NETs in S. aureus-infected bone marrow-derived
neutrophils from both WT and AIM2-/- mice by fluorimetry. To further confirm the NETosis
results, we can perform western blotting experiments with the PAD4 and Cit-H3 markers, which
are hallmarks of NETosis. There is a well-orchestrated de novo production of neutrophils in the
bone marrow, which are mobilized to the site of infection through a mechanism known as
emergency granulopoiesis22. In order to determine the role of the AIM2 inflammasome in
emergency granulopoiesis and neutrophil recruitment to the infection site, flow cytometry
experiments can be done with cell surface markers of granulopoiesis, including c-Kit and Ly-6G.
One of the major modes of cell death is pyroptosis, which is dependent on caspase-1 and
brought about by gasdermin-D140-142. Although pyroptosis plays a major role in regulating
intracellular bacterial infections, extensive pyroptosis and subsequent caspase-1 activation have
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been shown to exaggerate the severity of many diseases including myocardial infarction143,
inflammatory bowel disease, and endotoxic shock143. Therefore, we could also investigate whether
AIM2-dependent pyroptosis is responsible for the severity of S. aureus infection.
It is generally acknowledged that both hematopoietic and non-hematopoietic cells play
essential roles in pulmonary bacterial infections. In this context, we can generate bone marrow
chimeras to differentiate whether AIM2 expression in hematopoietic or non-hematopoietic cells is
detrimental in S. aureus-induced pneumonia. Another future direction is to determine whether the
interaction of AIM2 with other inflammasomes, like NLRP3 or NLRC4, increases or decreases
host susceptibility to S. aureus infection using double knockout mice.
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